US2015258133A1PendingUtilityA1

Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases

43
Assignee: UNIV LIEGEPriority: Oct 10, 2004Filed: Apr 29, 2015Published: Sep 17, 2015
Est. expiryOct 10, 2024(expired)· nominal 20-yr term from priority
Inventors:Didier CataldoBrigitte EvrardAgnes NoelJean-Michel Foldart
A61K 31/724A61K 9/0078A61K 9/0073A61P 11/00
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides the use of a cyclodextrin compound for the manufacturing of a medicament for the treatment or prevention of bronchial inflammatory diseases, particularly for asthma and chronic obstructive pulmonary disease (COPD).

Claims

exact text as granted — not AI-modified
1 - 3 . (canceled) 
     
     
         4 . A method for the treatment of COPD (chronic obstruction pulmonary disease) in a host mammal in need of such treatment, comprising the step of administering in an aerosol, a pharmaceutical composition consisting essentially of hydroxypropyl beta-cyclodextrin in a concentration of from 10-75 mM.

Join the waitlist — get patent alerts

Track US2015258133A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.